Trade Schrödinger, Inc. - SDGR CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.33 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026151% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003929% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Schrodinger Inc ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Prev. Close* | 27.44 |
Open* | 26.98 |
1-Year Change* | 8.22% |
Day's Range* | 26.72 - 27.37 |
52 wk Range | 15.85-59.24 |
Average Volume (10 days) | 630.76K |
Average Volume (3 months) | 30.08M |
Market Cap | 2.50B |
P/E Ratio | 40.26 |
Shares Outstanding | 81.04M |
Revenue | 193.79M |
EPS | 0.86 |
Dividend (Yield %) | N/A |
Beta | 1.29 |
Next Earnings Date | Nov 1, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Oct 2, 2023 | 27.44 | -0.44 | -1.58% | 27.88 | 28.16 | 27.07 |
Sep 29, 2023 | 28.22 | 0.32 | 1.15% | 27.90 | 28.37 | 27.50 |
Sep 28, 2023 | 27.28 | -0.17 | -0.62% | 27.45 | 27.77 | 27.00 |
Sep 27, 2023 | 27.12 | -0.23 | -0.84% | 27.35 | 28.02 | 26.81 |
Sep 26, 2023 | 27.31 | -0.51 | -1.83% | 27.82 | 28.25 | 26.87 |
Sep 25, 2023 | 28.18 | -0.20 | -0.70% | 28.38 | 28.81 | 27.79 |
Sep 22, 2023 | 28.96 | -0.71 | -2.39% | 29.67 | 30.08 | 28.60 |
Sep 21, 2023 | 29.45 | -0.50 | -1.67% | 29.95 | 30.23 | 29.45 |
Sep 20, 2023 | 30.67 | -0.48 | -1.54% | 31.15 | 31.65 | 30.54 |
Sep 19, 2023 | 31.10 | -0.17 | -0.54% | 31.27 | 31.87 | 30.80 |
Sep 18, 2023 | 31.68 | -0.41 | -1.28% | 32.09 | 32.22 | 30.95 |
Sep 15, 2023 | 32.76 | -0.25 | -0.76% | 33.01 | 33.20 | 32.28 |
Sep 14, 2023 | 33.13 | -0.12 | -0.36% | 33.25 | 33.95 | 32.77 |
Sep 13, 2023 | 33.15 | -0.18 | -0.54% | 33.33 | 34.33 | 33.00 |
Sep 12, 2023 | 33.61 | 0.16 | 0.48% | 33.45 | 33.99 | 33.45 |
Sep 11, 2023 | 33.90 | -0.19 | -0.56% | 34.09 | 34.49 | 33.68 |
Sep 8, 2023 | 33.83 | -0.67 | -1.94% | 34.50 | 34.83 | 33.75 |
Sep 7, 2023 | 34.72 | -0.13 | -0.37% | 34.85 | 35.10 | 33.95 |
Sep 6, 2023 | 35.50 | -0.10 | -0.28% | 35.60 | 36.27 | 34.97 |
Sep 5, 2023 | 35.69 | -0.53 | -1.46% | 36.22 | 36.28 | 34.94 |
Schrödinger, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
Wednesday, November 1, 2023 | ||
Time (UTC) 10:59 | Country US
| Event Q3 2023 Schrodinger Inc Earnings Release Q3 2023 Schrodinger Inc Earnings ReleaseForecast -Previous - |
Monday, February 26, 2024 | ||
Time (UTC) 21:00 | Country US
| Event Q4 2023 Schrodinger Inc Earnings Release Q4 2023 Schrodinger Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 180.955 | 137.931 | 108.095 | 85.543 | 66.639 |
Revenue | 180.955 | 137.931 | 108.095 | 85.543 | 66.639 |
Cost of Revenue, Total | 79.933 | 72.311 | 44.623 | 36.45 | 23.702 |
Gross Profit | 101.022 | 65.62 | 63.472 | 49.093 | 42.937 |
Total Operating Expense | 327.772 | 249.374 | 169.011 | 124.258 | 94.608 |
Selling/General/Admin. Expenses, Total | 120.954 | 86.159 | 59.693 | 46.291 | 34.259 |
Research & Development | 126.372 | 90.904 | 64.695 | 38.786 | 34.215 |
Operating Income | -146.817 | -111.443 | -60.916 | -38.715 | -27.969 |
Interest Income (Expense), Net Non-Operating | -2.309 | 10.635 | 34.624 | 12.743 | -0.379 |
Net Income Before Taxes | -149.126 | -100.808 | -26.292 | -25.972 | -28.348 |
Net Income After Taxes | -149.189 | -101.219 | -26.637 | -25.681 | -28.425 |
Net Income Before Extra. Items | -149.186 | -100.393 | -24.463 | -24.571 | -28.425 |
Total Extraordinary Items | |||||
Net Income | -149.186 | -100.393 | -24.463 | -24.571 | -28.425 |
Income Available to Common Excl. Extra. Items | -149.186 | -100.393 | -24.463 | -24.571 | -28.425 |
Income Available to Common Incl. Extra. Items | -149.186 | -100.393 | -24.463 | -24.571 | -28.425 |
Diluted Net Income | -149.186 | -100.393 | -24.463 | -24.571 | -28.425 |
Diluted Weighted Average Shares | 71.1734 | 70.5949 | 60.0247 | 61.4472 | 61.4472 |
Diluted EPS Excluding Extraordinary Items | -2.09609 | -1.4221 | -0.40755 | -0.39987 | -0.46259 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
Diluted Normalized EPS | -2.09609 | -1.4221 | -0.40755 | -0.39987 | -0.46259 |
Depreciation / Amortization | 0.513 | 2.731 | 2.432 | ||
Minority Interest | 0.003 | 0.826 | 2.174 | 1.11 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 35.189 | 64.782 | 56.843 | 36.98 | 38.469 |
Revenue | 35.189 | 64.782 | 56.843 | 36.98 | 38.469 |
Cost of Revenue, Total | 21.379 | 19.089 | 18.139 | 19.779 | 21.335 |
Gross Profit | 13.81 | 45.693 | 38.704 | 17.201 | 17.134 |
Total Operating Expense | 96.322 | 95.283 | 85.381 | 83.143 | 81.942 |
Selling/General/Admin. Expenses, Total | 32.238 | 35.453 | 32.7 | 30.479 | 29.484 |
Research & Development | 42.705 | 40.741 | 34.542 | 32.885 | 31.123 |
Operating Income | -61.133 | -30.501 | -28.538 | -46.163 | -43.473 |
Interest Income (Expense), Net Non-Operating | 40.654 | 185.996 | 1.194 | 6.501 | -3.872 |
Net Income Before Taxes | -16.153 | 155.495 | -27.344 | -39.662 | -47.653 |
Net Income After Taxes | 4.278 | 129.136 | -27.208 | -39.856 | -47.686 |
Minority Interest | 0.001 | 0.003 | |||
Net Income Before Extra. Items | 4.278 | 129.136 | -27.207 | -39.853 | -47.686 |
Net Income | 4.278 | 129.136 | -27.207 | -39.853 | -47.686 |
Income Available to Common Excl. Extra. Items | 4.278 | 129.136 | -27.207 | -39.853 | -47.686 |
Income Available to Common Incl. Extra. Items | 4.278 | 129.136 | -27.207 | -39.853 | -47.686 |
Diluted Net Income | 4.278 | 129.136 | -27.207 | -39.853 | -47.686 |
Diluted Weighted Average Shares | 75.0643 | 73.8186 | 71.2716 | 71.208 | 71.1619 |
Diluted EPS Excluding Extraordinary Items | 0.05699 | 1.74937 | -0.38174 | -0.55967 | -0.67011 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | 0.05699 | 1.74937 | -0.38174 | -0.55967 | -0.67011 |
Other, Net | 4.326 | -0.308 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 533.989 | 625.06 | 682.978 | 118.536 | 104.69 |
Cash and Short Term Investments | 451.087 | 576.479 | 642.691 | 85.83 | 84.067 |
Cash & Equivalents | 90.474 | 120.267 | 202.296 | 25.986 | 77.716 |
Short Term Investments | 360.613 | 456.212 | 440.395 | 59.844 | 6.351 |
Total Receivables, Net | 69.09 | 40.551 | 35.378 | 25.738 | 18.021 |
Accounts Receivable - Trade, Net | 67.331 | 40.015 | 35.012 | 25.58 | 17.995 |
Prepaid Expenses | 8.569 | 5.03 | 4.409 | 6.468 | 2.602 |
Total Assets | 688.587 | 756.487 | 746.263 | 155.27 | 120.73 |
Property/Plant/Equipment, Total - Net | 120.226 | 85.409 | 15.269 | 19.03 | 7.967 |
Property/Plant/Equipment, Total - Gross | 134.339 | 97.764 | 29.071 | 29.592 | 17.4 |
Accumulated Depreciation, Total | -14.113 | -12.355 | -13.802 | -10.562 | -9.433 |
Intangibles, Net | 0.587 | 0 | 0.015 | ||
Long Term Investments | 25.683 | 43.167 | 45.664 | 15.366 | 5.444 |
Other Long Term Assets, Total | 3.311 | 2.851 | 2.352 | 2.338 | 2.614 |
Total Current Liabilities | 108.799 | 91.211 | 73.205 | 45.02 | 27.005 |
Accounts Payable | 9.47 | 8.079 | 8.398 | 3.524 | 2.773 |
Accrued Expenses | 41.398 | 27.764 | 19.404 | 16.442 | 6.587 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 57.931 | 55.368 | 45.403 | 25.054 | 17.645 |
Total Liabilities | 240.693 | 199.416 | 122.248 | 57.054 | 30.603 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Liabilities, Total | 131.883 | 108.191 | 49.039 | 11.993 | 3.598 |
Total Equity | 447.894 | 557.071 | 624.015 | 98.216 | 90.127 |
Preferred Stock - Non Redeemable, Net | 0 | 191.58 | 161.687 | ||
Common Stock | 0.714 | 0.71 | 0.699 | 0.061 | 0.059 |
Additional Paid-In Capital | 828.7 | 786.964 | 752.558 | 11.655 | 8.915 |
Retained Earnings (Accumulated Deficit) | -379.138 | -229.952 | -129.559 | -105.096 | -80.525 |
Other Equity, Total | -2.382 | -0.651 | 0.317 | 0.016 | -0.009 |
Total Liabilities & Shareholders’ Equity | 688.587 | 756.487 | 746.263 | 155.27 | 120.73 |
Total Common Shares Outstanding | 71.3279 | 70.9987 | 69.8777 | 61.4472 | 61.4472 |
Other Current Assets, Total | 5.243 | 3 | 0.5 | 0.5 | |
Minority Interest | 0.011 | 0.014 | 0.004 | 0.041 | |
Goodwill, Net | 4.791 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 603.734 | 533.989 | 524.201 | 556.872 | 586.168 |
Cash and Short Term Investments | 527.688 | 451.087 | 473.556 | 509.565 | 525.532 |
Cash & Equivalents | 233.206 | 90.474 | 102.817 | 127.319 | 117.257 |
Short Term Investments | 294.482 | 360.613 | 370.739 | 382.246 | 408.275 |
Total Receivables, Net | 60.164 | 69.09 | 35.738 | 31.745 | 45.594 |
Accounts Receivable - Trade, Net | 60.272 | 67.331 | 34.64 | 30.782 | 44.086 |
Prepaid Expenses | 11.396 | 8.569 | 9.104 | 12.062 | 11.542 |
Other Current Assets, Total | 4.486 | 5.243 | 5.803 | 3.5 | 3.5 |
Total Assets | 838.773 | 688.587 | 661.985 | 687.88 | 719.537 |
Property/Plant/Equipment, Total - Net | 122.475 | 120.226 | 102.217 | 101.657 | 89.256 |
Long Term Investments | 101.539 | 25.683 | 27.177 | 21.903 | 37.002 |
Other Long Term Assets, Total | 6.234 | 3.311 | 2.879 | 1.804 | 1.334 |
Total Current Liabilities | 123.407 | 108.799 | 88.821 | 85.59 | 85.532 |
Accounts Payable | 11.987 | 9.47 | 10.918 | 5.263 | 9.766 |
Accrued Expenses | 33.524 | 41.398 | 33.983 | 32.887 | 21.995 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 77.896 | 57.931 | 43.92 | 47.44 | 53.771 |
Total Liabilities | 248.513 | 240.693 | 198.875 | 194.822 | 188.87 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0.011 | 0.012 | 0.015 | 0.003 | |
Other Liabilities, Total | 125.106 | 131.883 | 110.042 | 109.217 | 103.335 |
Total Equity | 590.26 | 447.894 | 463.11 | 493.058 | 530.667 |
Common Stock | 0.715 | 0.714 | 0.712 | 0.712 | 0.712 |
Additional Paid-In Capital | 840.446 | 828.7 | 818.015 | 807.827 | 797.004 |
Retained Earnings (Accumulated Deficit) | -250.002 | -379.138 | -351.931 | -312.078 | -264.392 |
Other Equity, Total | -0.899 | -2.382 | -3.686 | -3.403 | -2.657 |
Total Liabilities & Shareholders’ Equity | 838.773 | 688.587 | 661.985 | 687.88 | 719.537 |
Total Common Shares Outstanding | 71.5262 | 71.3279 | 71.232 | 71.1913 | 71.1366 |
Goodwill, Net | 4.791 | 4.791 | 4.791 | 4.791 | 4.791 |
Intangibles, Net | 0 | 0.587 | 0.72 | 0.853 | 0.986 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -149.189 | -101.219 | -26.637 | -25.681 | -28.425 |
Cash From Operating Activities | -119.683 | -70.669 | 16.757 | -26.059 | -23.711 |
Cash From Operating Activities | 4.344 | 2.847 | 3.658 | 3.64 | 2.894 |
Non-Cash Items | 46.537 | 23.026 | -19.44 | -8.313 | 1.539 |
Cash Taxes Paid | 0.787 | 0.448 | 0.381 | 0.139 | 0.013 |
Changes in Working Capital | -21.375 | 4.677 | 59.176 | 4.295 | 0.281 |
Cash From Investing Activities | 90.023 | -16.812 | -381.721 | -53.855 | 11.194 |
Capital Expenditures | -8.014 | -7.167 | -2.538 | -1.836 | -5.259 |
Other Investing Cash Flow Items, Total | 98.037 | -9.645 | -379.183 | -52.019 | 16.453 |
Cash From Financing Activities | 2.11 | 7.952 | 541.274 | 28.684 | 80.273 |
Issuance (Retirement) of Stock, Net | 2.11 | 7.927 | 541.274 | 30.442 | 80.273 |
Net Change in Cash | -27.55 | -79.529 | 176.31 | -51.23 | 67.756 |
Financing Cash Flow Items | 0 | 0.025 | 0 | -1.758 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 129.136 | -149.189 | -121.981 | -82.125 | -34.44 |
Cash From Operating Activities | -31.094 | -119.683 | -94.741 | -64.378 | -39.711 |
Cash From Operating Activities | 1.76 | 4.344 | 3.202 | 2.095 | 0.969 |
Non-Cash Items | -173.143 | 46.537 | 36.307 | 31.31 | 16.798 |
Cash Taxes Paid | 0.086 | 0.787 | 0.462 | 0.171 | 0.037 |
Changes in Working Capital | 11.153 | -21.375 | -12.269 | -15.658 | -23.038 |
Cash From Investing Activities | 172.202 | 90.023 | 78.466 | 70.626 | 36.304 |
Capital Expenditures | -3.58 | -8.014 | -6.668 | -3.67 | -1.696 |
Other Investing Cash Flow Items, Total | 175.782 | 98.037 | 85.134 | 74.296 | 38 |
Cash From Financing Activities | 0.867 | 2.11 | 1.628 | 1.304 | 0.908 |
Issuance (Retirement) of Stock, Net | 0.867 | 2.11 | 1.628 | 1.304 | 0.908 |
Net Change in Cash | 141.975 | -27.55 | -14.647 | 7.552 | -2.499 |
Financing Cash Flow Items | 0 | 0 | 0 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Schrödinger, Inc. Company profile
Schrödinger (SDGR) is a computational platform that facilitates the discovery of molecules for drug development and materials design for biopharmaceutical, academic institutions and government laboratories.
Founded in 1990, Schrödinger is headquartered in New York. The company has customers and collaborators across more than 70 countries. Its collaborators include Agios Therapeutics, Ajax Therapeutics, Bright Angel Therapeutics, Eli Lilly and Company and Sanofi.
Schrödinger specialises in oncology, antifungal, fibrosis, inflammatory bowel diseases, metabolic diseases, cardiopulmonary diseases, tuberculosis, neurodegenerative disease and more.
MALT1 inhibitor is a key regulator of physiological antigen receptor signalling in B cells and T cells and are additive to covalent and non-covalent BTK inhibitors. The company announced US Food and Drug Administration (FDA) clearance of an investigational new drug application for SGR-1505, a MALT1 Inhibitor.
Schrödinger leverages the software platform to advance its collaborative programmes and its novel therapeutics pipeline includes eight compounds that address unmet medical needs and are currently in the clinical development phase.
Schrödinger, Inc. stock began trading on the NASDAQ in 2020 under the ticker symbol SDGR.
You can track live SDGR share value and price history at Capital.com.
Industry: | Software (NEC) |
1540 Broadway
24th Floor
NEW YORK
NEW YORK 10036
US
Income Statement
- Annual
- Quarterly
News

How to Trade The Triple Top
Welcome to Part 5 of our 7-part Power Patterns series. In this series, we'll be equipping you with the skills to trade some of the most indicative price patterns which occur on any timeframe in every market.
14:13, 27 September 2023
Q4 lookahead: US indices starting to show signs of trouble?
US indices start to draw attention as traders focus on the outlook for Q4.
07:20, 27 September 2023
USD/JPY Climbs Towards Key Highs
USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.
11:32, 26 September 2023
EUR/USD tests key support
EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.
14:32, 21 September 2023
BoE leaves rates unchanged, GBP drops further as investors look for more clarity
The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August
11:45, 21 September 2023
GBP softer after CPI surprise, JPY focused on any further hints from Ueda
GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.
12:42, 20 September 2023
How to Trade The Break & Retest
In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.
11:59, 20 September 2023People also watch
Still looking for a broker you can trust?
Join the 555.000+ traders worldwide that chose to trade with Capital.com